References
- Brasher G W. Clinical aspects of infantile asthmas. Ann Allergy 1975; 35: 216
- Dodge R R, Burrows. The prevalence and incidence of asthma and asthma-like symptoms in a general population sample. Am Res Resp Dis 1980; 122: 567
- McConnochie K M. Bronchiolitis: What's in a name?. Am J Dis Child 1983; 137: 11
- Eigen H, Laughlin J, Homrighausen J. Recurrent pneumonia in children and its relationship to bronchial hyperactivity. Pediatrics 1982; 70: 698
- Hogg J C, Williams J, Richardson J B, Macklem P T, Thurlbeck W M. Age as a factor in the distribution of lower airway conductance and in the pathologic anatomy of obstructive lung disease. N Eng J Med 1970; 292: 1283
- Lenney W, Milner A D. At what age do bronchodilator drugs work?. Arch Dis Child 1978; 53: 532
- Bell T, Bigley J. Sustained-release theophylline therapy for chronic childhood asthma. Pediatrics 1978; 62: 352
- Weinberger M, Bronsky E A. Evaluation of oral bronchodilator therapy in asthmatic children. J Pe-diatr 1974; 84: 421
- Tabachnik E, Levison H. Infantile bronchial asthma. J Allergy Clin Immunol 1981; 67: 339
- Ginchansky E, Weinberger M. Relationship of theophylline clearance to oral dosage in children with chronic asthma. J Pediatr 1977; 91: 655
- Levy G, Koysooko R. Pharmacokinetic analysis of the effect of theophylline on pulmonary function in asthmatic children. J Pediatr 1975; 86: 789
- Weinberger M, Hendeles L, Wong L, Vaughan L. Relationship of formulation and dosing interval to fluctuation of serum theophylline concentration in children with chronic asthma. J Pediatr 1981; 99: 145
- Eney R D, Goldstein E. Compliance of chronic asthmatics with oral administration of theophylline as measured by serum theophylline and salivary levels. Pediatrics 1976; 57: 513
- Pollack J, Kiechel F, Cooper D. Relationship of serum theophylline concentration to inhibition of exercise-induced bronchospasm and comparison with cromolyn. Pediatrics 1977; 60: 840
- Ogilvie R I. Clinical pharmacokinetics of theophylline. Clin Pharmacokinet 1978; 3: 267
- Loughnan P M, Sitar D S, Ogilvie R I, Eisen A, Fox Z, Neims A. Pharmacokinetic analysis of the disposition of intravenous theophylline in young children. J Pediatr 1976; 88: 874
- Zaske D E, Miller K, Strem E, Austrian S, Johnson P. Oral aminophylline therapy. J Am Med Assoc 1977; 237: 1453
- Scott P S, Tabachnik E, MacLeod S, Correia J, Newth C, Levison H. Sustained-release theophylline for childhood asthma: Evidence for cir-cadian variation of theophylline pharmacokinetics. J Pediatr 1981; 99: 476
- Kelly H W, Murphy S. Serum theophylline levels in asthmatic children receiving sustained-release theophylline tablets. Am J Hosp Pharmacol 1979; 36: 1698
- Kelly H W, Murphy S. Efficacy of a 12-hour sustained-release preparation in maintaining therapeutic serum theophylline levels in asthmatic children. Pediatrics 1980; 66: 97
- McKenzie S, Baille E. Serum theophylline levels in asthmatic children after oral administration of two slow-release theophylline preparations. Arch Dis Child 1978; 53: 943
- Simons F E, Luciuk G H, Simons K J. Sustained-release theophylline for treatment of asthma in pre-school children. Am J Dis Child 1982; 136: 790
- Howard M E, Kobayashi R H, Baldwin J. Oral absorption of Quibron T-S/R in young children, (unpublished).
- Kobayashi R H, Swigart S, Baldwin J. Evaluation of a sustained-release theophylline preparation in young children, (unpublished).
- Weinberger M. Theophylline for treatment of asthma. J Pediatr 1978; 92: 1
- Hendeles L, Weinberger M, Wyatt R. Guide to oral theophylline therapy for the treatment of chronic asthma. Am J Dis Child 1978; 132: 876
- Weinberger M. Management of asthma—A correction (letter to the editor). Pediatrics 1982; 69: 663
- Hendeles L, Weinberger M. Avoidance of adverse effects during chronic therapy with theophylline. Eur J Resp Dis Suppl 1980; 61(109)103
- Weinberger M, Ginchansky E. Dose-dependent kinetics for theophylline disposition in asthmatic children. J Pediatr 1977; 91: 820